| Literature DB >> 26083872 |
Maïté Amy1,2, Oliver Staehlin3, Frédérique René4,5, Hélène Blasco1,2,6, Sylviane Marouillat1, Hussein Daoud1, Patrick Vourc'h1,2,6, Paul H Gordon7, William Camu8, Philippe Corcia1,2,9, Jean-Philippe Loeffler4,5, Miklós Palkovits10, Wolfgang H Sommer3, Christian R Andres1,2,6.
Abstract
Amyotrophic lateral sclerosis is sporadic (SALS) in 90% of cases and has complex environmental and genetic influences. Nogo protein inhibits neurite outgrowth and is overexpressed in muscle in ALS. Our aims were to study the reticulon 4 receptor gene RTN4R which encodes Nogo 1 receptor (NgR1) in SALS, to test if the variants were associated with variable expression of the gene and whether NgR1 protein expression was modified in a transgenic mouse model of ALS. We genotyped three single nucleotide polymorphisms (SNPs; rs701421, rs701427, and rs1567871) of the RTN4R gene in 364 SALS French patients and 430 controls. We examined expression of RTN4R mRNA by quantitative PCR in control post mortem human brain tissue. We determined the expression of NgR1 protein in spinal motor neurons from a SOD1 G86R ALS mouse model. We observed significant associations between SALS and RTN4R alleles. Messenger RNA expression from RTN4R in human cortical brain tissue correlated significantly with the genotypes of rs701427. NgR1 protein expression was reduced in Nogo A positive motor neurons from diseased transgenic animals. In conclusion, these observations suggest that a functional RTN4R gene variant is associated with SALS. This variant may act in concert with other genetic variants or environmental influences.Entities:
Keywords: Nogo-66 receptor; SNP; association study; gene expression; motor neurons; reticulon 4 receptor gene (RTN4R); sporadic amyotrophic lateral sclerosis
Mesh:
Substances:
Year: 2015 PMID: 26083872 DOI: 10.3109/21678421.2015.1051988
Source DB: PubMed Journal: Amyotroph Lateral Scler Frontotemporal Degener ISSN: 2167-8421 Impact factor: 4.092